Methodological Advantages Mask Critical Design Limitations The Allen Brain SEA-AD MTG dataset represents an ambitious single-nucleus RNA sequencing (snRNA-seq) effort targeting the middle temporal gyrus in Alzheimer's disease brains. While this resource provides unprecedented cellular resolution, I argue that three fundamental methodological challenges significantly undermine its interpretive value: (1) systematic spatial information loss inherent to nuclear isolation, (2) inadequate handling of inter-individual neuropathological heterogeneity, and (3) statistical frameworks insufficient for modeling the complex, non-linear relationships characteristic of AD progression. First, the snRNA-seq approach sacrifices spatial context—a critical dimension when examining a disease fundamentally defined by stereotypic spreading patterns. The Braak staging model demonstrates that AD pathology propagates through anatomically connected circuits, yet nuclear dissociation eliminates the very topological information required to model such propagation.
...
Methodological Advantages Mask Critical Design Limitations The Allen Brain SEA-AD MTG dataset represents an ambitious single-nucleus RNA sequencing (snRNA-seq) effort targeting the middle temporal gyrus in Alzheimer's disease brains. While this resource provides unprecedented cellular resolution, I argue that three fundamental methodological challenges significantly undermine its interpretive value: (1) systematic spatial information loss inherent to nuclear isolation, (2) inadequate handling of inter-individual neuropathological heterogeneity, and (3) statistical frameworks insufficient for modeling the complex, non-linear relationships characteristic of AD progression. First, the snRNA-seq approach sacrifices spatial context—a critical dimension when examining a disease fundamentally defined by stereotypic spreading patterns. The Braak staging model demonstrates that AD pathology propagates through anatomically connected circuits, yet nuclear dissociation eliminates the very topological information required to model such propagation. Without knowing where a cell resided within its native tissue architecture, we cannot distinguish primary病变 sites from downstream effects. While the Allen Institute has begun incorporating spatial transcriptomics platforms, the current MTG dataset stands as an isolated snapshot divorced from spatial embedding. Second, the dataset's statistical framework inadequately models disease heterogeneity. Alzheimer's disease manifests along multiple molecular trajectories, yet most analyses in this resource employ group-level comparisons (AD vs. control) that collapse biologically distinct subtypes into artificial categories. The recent recognition that approximately 20-30% of clinically diagnosed AD subjects lack expected amyloid/tau pathology underscores the danger of treating AD as a monolithic entity. Without explicit modeling of mixed pathology burdens (e.g., AD with Lewy body disease, vascular contributions), cell type proportion shifts attributed to "AD" may actually reflect sub-cohort-specific phenomena not generalizable across the broader patient population.
Supporting Evidence and Predictions The ssREAD database compilation (Wang et al., 2023) confirms that the field increasingly recognizes the need for integrated spatial-transcriptomic approaches rather than isolated snRNA-seq datasets. Studies examining microglial states in AD have demonstrated that the same myeloid transcriptional programs appear in dis